MULTIPLE STREAMS OF REVENUE, Big announcements on the horizon. They didn’t upgrade the plant because they were board. TIME TO CAPITALIZE ON THE LACTOACTIVE PATENT!IMO
“licensing out our Lactoactive®molecule for the pharmaceutical industry.”
Vilacto Bio Inc. Upgrades Denmark Plant; Paves Way for New LACTOACTIVE iTHER® to Stimulate Local Antibody ProductionPress Release | 05/23/2018
We aim to further develop our Lactoactive®molecule for the purpose of increasing the quality of our retail and medical skin cream products as well as licensing out our Lactoactive®molecule for the pharmaceutical industry.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.